Pharmacodynamics of Pre-Operative PD1 CheckpOint Blockade and Receptor Activator of NF-κB Ligand (RANKL) Inhibition in Non-Small Cell Lung Cancer (NSCLC) – a phase 1B/2 trial

Project: Research

Project Details

StatusActive
Effective start/end date6/10/21 → 5/10/26

Keywords

  • Pharmacodynamics
  • lung cancer
  • phase 1 and 2 study
  • treatment efficacy
  • treatment safety